Understanding pathways of normal myeloid development and leukemic dysregulation of myeloid self-renewal programs. As a model system, I have focused on acute promyelocytic leukemia, which is associated with the t(15;17) translocation and the PML-RARA fusion oncoprotein. Initial exposure of hematopoietic cells to PML-RARA leads to inappropriate self-renewal but not myeloproliferation. We are now focusing on understanding programs that lead to dysregulated self-renewal by PML-RARA, especially retinoid receptor-dependent pathways.
- 2002: PhD, biomedical sciences, University of California, San Diego
- 2004: MD, University of California, San Diego
- 2004 - 2006: Intern and resident, internal medicine, Washington University, St. Louis
- 2006 - 2010: Fellow, hematology and oncology, Washington University
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.